You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Docetaxel

Showing 26 - 50 of 3,166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),

Not yet recruiting
  • Locally Advanced Unresectable Esophageal Squamous Carcinoma
  • Docetaxel for Injection (Albumin-bound)
  • +4 more
  • Jinan, Shandong, China
  • +1 more
Nov 16, 2023

Peritoneal Carcinomatosis Trial in Baltimore (Intraperitoneal docetaxel)

Recruiting
  • Peritoneal Carcinomatosis
  • Intraperitoneal docetaxel
  • Baltimore, Maryland
    Johns Hopkins University
Nov 7, 2022

Pancreatic Cancer Trial in Shanghai (Docetaxel for injection (Albumin-bound))

Not yet recruiting
  • Pancreatic Cancer
  • Docetaxel for injection (Albumin-bound)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 13, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Bellinzona, Chur, St. Gallen (Docetaxel micellar)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Docetaxel micellar
  • Bellinzona, Switzerland
  • +2 more
Nov 7, 2022

Breast Cancer Trial (Utidelone Injection in combination with AC, Docetaxel Injection in combination with AC)

Not yet recruiting
  • Breast Cancer
  • Utidelone Injection in combination with AC
  • Docetaxel Injection in combination with AC
  • (no location specified)
Jan 10, 2023

HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

Active, not recruiting
  • HER2-positive Breast Cancer
  • TQB2440 injection + Trastuzumab + Docetaxel
  • Perjeta + Trastuzumab + Docetaxel
  • Chongqing, Chongqing, China
  • +5 more
Aug 3, 2023

Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

Active, not recruiting
  • Non-muscle-invasive Bladder Cancer
  • Gemcitabine 1000 mg, Docetaxel 37.5g
  • Zagreb, Croatia
    University Hospital Centre Zagreb
Jan 20, 2023

Platinum-resistant Recurrent Ovarian Cancer Trial in Wuhan (Docetaxel for injection (Albumin-bound), Bevacizumab)

Recruiting
  • Platinum-resistant Recurrent Ovarian Cancer
  • Wuhan, Hubei, China
    Tongji Hospital,Tongji Medical College of HUST
Oct 12, 2022

Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

Completed
  • Breast Neoplasms
  • Shanghai, Shanghai, China
    Ruijin Hospital
Oct 26, 2022

High-grade Salivary Gland Carcinoma Trial in Seoul (nivolumab, docetaxel, cisplatin Group)

Recruiting
  • High-grade Salivary Gland Carcinoma
  • nivolumab, docetaxel, cisplatin Group
  • Seoul, Korea, Republic of
    Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Feb 3, 2023

HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,

Not yet recruiting
  • HER2-PositiveRecurrent or Metastatic Breast Cancer
  • SHR-A1811 Injection
  • +2 more
  • (no location specified)
Sep 21, 2023

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • +4 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Prostate Cancer, Castration-resistant Prostate Cancer Trial in São Paulo (Docetaxel, Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • São Paulo, SP, Brazil
    Instituto do Câncer do Estado de São Paulo
Sep 14, 2022

Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)

Recruiting
  • Gastric Cancer, Adjuvant Chemotherapy, XO
  • Docetaxel and capecitabine and oxaliplatin
  • capecitabine and oxaliplatin
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

Hyperthermic Intraperitoneal Chemo Trial in Guangzhou (Docetaxel)

Recruiting
  • Hyperthermic Intraperitoneal Chemotherapy
  • Docetaxel
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen Memorial Hospital
Jun 6, 2022

NSCLC Trial (Pembrolizumab, Docetaxel)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Pembrolizumab
  • Docetaxel
  • (no location specified)
Aug 18, 2022

Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Davis, California
  • +2 more
Jan 5, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

Breast Cancer, Lung Cancer, Prostate Cancer Trial in Salt Lake City (Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel) plus Dietary Supplement (RaproCell)
  • +2 more
  • Salt Lake City, Utah
    Optimal Health Research
Oct 18, 2022

Oral Squamous Cell Carcinoma Trial in Shanghai (Camrelizumab Plus Docetaxel and Cisplatin)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Camrelizumab Plus Docetaxel and Cisplatin
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Ton
Nov 9, 2022

Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

Recruiting
  • Hormone Sensitive Metastatic Prostate Cancer
  • +3 more
  • Docetaxel
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022

Triple-Negative Breast Cancer Trial in Guangzhou (DCb (docetaxel/carboplatin) versus EC followed by D

Completed
  • Triple-Negative Breast Cancer
  • DCb (docetaxel/carboplatin) versus EC followed by D (epirubicin/cyclophosphamide followed by docetaxe)
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 27, 2022

Personalizing Docetaxel Dosing in Advanced Prostate Cancer

Active, not recruiting
  • Prostate Cancer
    • Portsmouth, United Kingdom
      Portsmouth Hospitals University NHS Trust
    Oct 25, 2022

    Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)

    Recruiting
    • Locally Advanced Gastric Adenocarcinoma
    • Chemotherapy Effect
    • Hanzhou, Zhejiang, China
      Gastrointestinal Department of Second Affiliated Hospital of Zhe
    Apr 2, 2023

    Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab in Combination with Plinabulin and Docetaxel)

    Not yet recruiting
    • Non Small Cell Lung Cancer Metastatic
    • Pembrolizumab in Combination with Plinabulin and Docetaxel
    • (no location specified)
    Oct 28, 2022